Please share/complete this survey aimed at raising awareness of ATMPs lnkd.in/gHZcDx38

Thousands of patients with sickle cell and thalassaemia, like Stephanie and Dean, can access a new gene test which helps to reduce the risk of painful side-effects of treatment. Find out about this cutting edge genotyping in collaboration with NHS Blood+Transplant. england.nhs.uk/2023/05/world-…

Our partners Cytiva and NHS Blood+Transplant have produced a document comparing liquid nitrogen and liquid nitrogen free controlled-rate freezing for the cryopreservation of MSCs. theattcnetwork.co.uk/news/cryoprese…

NEWS: SRPT today shared a program update related to SRP-9001. Read our press release: bit.ly/432xwKt

*New Publication* from our University of Manchester iMATCH team 🐝 Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy 👉 bitly.ws/G5dA

Health Secretary Michael Matheson MSP has opened a new laboratory for cutting-edge work into potentially life-saving gene therapies in Edinburgh BioQuarter. The innovative work led Cell and Gene Therapy Catapult will help ensure our healthcare systems are prepared for the future.

Future best practice recommendations coming soon for CAR-T patient referral pathways ct.catapult.org.uk/news/new-colla…

Read all about the survey results led by our partner Autolus. The analysis looks at and evaluates the current landscape for electronic cell orchestration platforms. theattcnetwork.co.uk/uncategorized/…

Excited to be attending the 25th Communiqué awards with our clients 🏥 Alder Hey 💙 Cell and Gene Therapy Catapult Gilead Sciences. Good luck to all the finalists! Communiqué #cxhealth

We have concluded a joint, successful project with the DMD Hub (Newcastle University) and the Cell and Gene Therapy Catapult, which has resulted in a publication that analyses the gene therapy patient referral pathways in the UK. gbr01.safelinks.protection.outlook.com/?url=https%3A%…

ATMP Engage: ensuring patients are at the heart of ATMP delivery and research - register below for this webinar next Wed 8/12/23 hosted by the ATTC network. event.on24.com/wcc/r/4374097/…

The future of access for patients to life changing advanced therapies lies in the hands of policy-makers and, in order to remain a life-sciences ‘superpower’, the UK needs to act now. bit.ly/46LxN5l #CellandGeneTherapy #AdvancedTherapies

In order to remain a life-sciences ‘superpower’ the UK needs to act now. The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. theattcnetwork.co.uk/network/attcs-…

In Oct influential, knowledgeable and experienced minds met The Royal Society of Medicine in London to discuss barriers and develop solutions to the UK Advanced Therapies Adoption Challenge Read the report theattcnetwork.co.uk/network/attcs-…

Doing nothing is not an option in the field of Advanced Therapies. This report describes how the UK can retain its lead in the field. theattcnetwork.co.uk/network/attcs-… #CellandGeneTherapy #AdvancedTherapies

In order to remain a life-sciences ‘superpower’ the UK needs to act now. The ‘Advanced Therapies Adoption Challenge in the United Kingdom’ report provides key recommendations to support action. theattcnetwork.co.uk/network/attcs-… #CellandGeneTherapy #AdvancedTherapies

Don’t miss this upcoming webinar hosted by the ATTC network on the 24 January 2024 at 1600 ‘Evaluation of the patient referral pathways for gene therapy and CAR-T in the UK’. Register here event.on24.com/wcc/r/4441182/…

We are delighted to share that the ATTC Network, co-ordinated by the CGT Catapult has received funding from the NIHR. This funding will allow continuation and enhancement of advanced therapy clinical trial initiatives. Here is the full story: ct.catapult.org.uk/news/17-9m-for…